Print Page

Medicine recalls

 
台灣:回收"瑞士"固糖平持續性藥效錠750毫克(二甲二脈) (Chinese only)
 
台灣衛生福利部食品藥物管理署公布,廠商自主回收效期內全批號由瑞士藥廠股份有限公司新市廠製造的"瑞士"固糖平持續性藥效錠750毫克(二甲二脈) Glucofit ER Tablets 750mg "SWISS"。

詳情請按以下連結: http://consumer.fda.gov.tw/../ProductDetail.aspx?nodeID=420&id=1502

在香港,上述產品並非註冊藥劑製品。

現時,在香港共有122種註冊藥劑製品含有甲福明(metformin)。所有產品屬醫生處方藥物。
各海外藥物監管局早前已公布有關在甲福明產品中檢測到N-亞硝基二甲胺(NDMA)的消息,而相關資訊已從2019年12月5日起刊登於藥物辦公室的網頁,最新的更新亦已於2020年8月21日刊登。衞生署已在2019年12月6日發信通知本地醫護專業人員。衞生署已聯絡所有本地註冊甲福明產品的註冊證書持有人以跟進這事件的本地影響。衞生署已在本地市場收集含有甲福明產品的樣本進行化驗。在發現任何對公眾構成健康風險時,會盡快作出公布。以下為已發出公布的主要內容:
- 2020年3月11日,衞生署同意持牌藥物批發商全球藥業有限公司從市面回收3個批次的Metformin-Teva 500毫克藥片(HK-60334) (批號: 16532717, 16532817及16532917),因產品可能含有雜質NDMA。
- 2020年7月22日,衞生署同意持牌藥物批發商新圖醫藥有限公司及何人可有限公司分別回收固糖平持續性藥效錠500毫克(Glucofit Extended-Release Tablets; HK-64640)和Diabetmin XR 長效500毫克藥片(HK-63333)。
- 2020年8月24日,衞生署同意持牌藥物批發商新圖醫藥有限公司回收固糖平膜衣錠500毫克(Glucofit Tablets; HK-64639)。

至今,衞生署接獲17宗涉及甲福明的藥物不良反應個案,但當中並沒有結論是與NDMA有關。衞生署會對這事件的發展和各海外藥物監管局就此藥物發出的安全更新保持警惕,以考慮任何必要的行動。

正在服用含有甲福明產品的病人不應自行停止服用藥物,他們應盡快向其醫護人員諮詢意見,以作適當安排。


2020年8月24日 (星期一)
香港時間20時30分
 
Related Information:
The United States: Viona Pharmaceuticals Inc., issues voluntary nationwide recal... Posted 2022-01-14
The United States: Viona Pharmaceuticals Inc. issues voluntary nationwide recall... Posted 2021-12-29
The United Kingdom: Class 2 Medicines Recall: Rosemont Pharmaceuticals Limited, ... Posted 2021-08-26
The United States: Viona Pharmaceuticals Inc., Issues Voluntary Nationwide Recal... Posted 2021-06-12
The United States: Nostrum Laboratories, Inc. expands voluntary nationwide recal... Posted 2021-01-26
The United States: Nostrum Laboratories, Inc. expands voluntary nationwide recal... Posted 2021-01-05
Australia : Recall - Blooms the Chemist Metformin XR 1000 metformin hydrochlorid... Posted 2020-11-18
The United States: Nostrum Laboratories, Inc. issues voluntary nationwide recall... Posted 2020-11-04
The United States: Nostrum Laboratories, Inc. issues voluntary nationwide recall... Posted 2020-11-03
The United States: Marksans Pharma Limited issues expansion of voluntary nationw... Posted 2020-10-06
The United States: Sun Pharmaceutical Industries, Inc. issues voluntary nationwi... Posted 2020-09-24
台灣:食藥署要求逐批檢驗含metformin成分藥品製劑 (Chinese only) Posted 2020-08-24
台灣:回收"瑞士"固糖平持續性藥效錠500毫克(二甲二脈) (Chinese only) Posted 2020-08-24
台灣:回收"瑞士"固糖平膜衣錠500毫克(二甲二脈) (Chinese only) Posted 2020-08-24
The United States: Bayshore Pharmaceuticals, LLC issues voluntary nationwide rec... Posted 2020-08-21
The United States: Update: Several companies voluntarily recall extended release... Posted 2020-07-14
The United States: Lupin Pharmaceuticals, Inc. issues voluntarily nationwide rec... Posted 2020-07-09
The United States: Granules Pharmaceuticals, Inc. issues voluntary nationwide re... Posted 2020-07-07
Canada: Recall: APO-Metformin 500 mg Extended Release Tablet Posted 2020-06-15
The United States: Lupin Pharmaceuticals, Inc. issues voluntarily nationwide rec... Posted 2020-06-12
The United States: Apotex Corp. issues voluntary nationwide recall of Metformin ... Posted 2020-06-06
The United States: Teva Pharmaceuticals USA, Inc. initiates voluntary nationwide... Posted 2020-06-06
The United States: Marksans Pharma Limited issues voluntary nationwide recall of... Posted 2020-06-06
The United States: Amneal Pharmaceuticals LLC issues voluntary nationwide recall... Posted 2020-06-02
The United States: Apotex Corp. issues voluntary nationwide recall of Metformin ... Posted 2020-05-29
Canada: Certain Metformin diabetes drugs recalled due to the presence or possibl... Posted 2020-03-12
Canada: Certain Metformin diabetes drugs recalled due to the presence of NDMA: U... Posted 2020-02-27
Canada: Recall: APO-Metformin 500mg Tablet (Extended-Release) Posted 2020-02-05
The United States: FDA posts laboratory testing results for NDMA levels in metfo... Posted 2020-02-04
Australia: Metformin: TGA investigation: potential contamination with N-nitrosod... Posted 2019-12-13
台灣:食藥署有關新加坡HSA回收metformin藥品事件說明 (Chinese only) Posted 2019-12-09
The United Kingdom: Metformin diabetes medicines – MHRA Update Posted 2019-12-07
European Union: EMA update on metformin diabetes medicines Posted 2019-12-07
The United States: Statement from Janet Woodcock, M.D., director of FDA’s Center... Posted 2019-12-06
Canada: Health Canada evaluating NDMA in metformin drugs Posted 2019-12-06
Some metformin medicines found to contain N-nitrosodimethylamine(NDMA) (Letter t... Posted 2019-12-06
Singapore: HSA Recalls Three out of 46 Metformin Medicines Posted 2019-12-05
 
back